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Introduction: Coronary bifurcation lesions account for 15–20% of all percutaneous coronary
interventions.
Dedicated bifurcation stents have recently been introduced with the aim to simplify
treatment and improve early and late outcomes following stenting of bifurcation lesions.
The purpose of our study was to assess the safety and effectiveness of the Tryton
dedicated side branch stent at a 6-month clinical and angiography follow-up.
Methods: Forty-two patients with bifurcation lesions were included in our study. The
primary endpoint was a 6-month MACE and angiographic stent patency was also evaluated
by MS-CT coronarography.
Results: Twenty-two patients (52.38%) were treated for acute coronary syndromes, 39 (92.85%)
lesions were ‘‘true bifurcations’’. The 6-month clinical follow-up was performed in all patients.
The 6-month MACE rate (cardiac death, myocardial infarction and target lesion revasculari-
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due to cardiogenic shock caused by early stent thrombosis and three patients (7.14%; 95% CI:
1.50–19.48%) required repeated revascularization (TVR) due to in-stent restenosis, all of them
in bare metal stents. Tryton stent implantation was successful in 100% lesions.
6-Month MS-CT coronarography was performed in 39 (92.85%) patients. The implanted
bifurcation Tryton stents were satisfactorily visualized in 97.43% of them and a satisfactory
6-month angiographic patency was demonstrated in 37 patients (88.1%).
Conclusion: The usage of a dedicated bifurcation Tryton Side Branch Stent for PCI of the
bifurcation lesions is technically feasible with satisfactory long-term results.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.
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.Introduction
Coronary bifurcation lesions account for 15–20% of all
percutaneous coronary interventions [1]. When compared to
non-bifurcation lesions, this lesion subset is considered
complex to treat, with inferior angiographic and clinical
results (acutely and at follow-up) [2].
Dedicated bifurcation stents have recently been intro-
duced with the aim to simplify treatment and improve
early and late outcomes following stenting of bifurcation
lesions.
When compared to the ‘‘classical’’ culotte technique, the
Tryton makes the procedure easier [3].
We aimed to assess in a prospective single-center
registry, safety and effectiveness at 6-month clinical and
angiography follow-up of the Tryton dedicated side branch
stent.Fig. 1 – Case 1, tight bifurcation stenosis Medina 1,1,1 at proxima
(B) right anterior oblique 258, cranial 408 view.Methods
Patient population
Patients with bifurcation lesions in whom a dedicated Tryton
Side Branch Stent was implanted at our Department during
2010–2013 were included in our registry.
The primary endpoint was a 6-month major adverse
cardiovascular events rate (MACE; cardiac death, myocardial
infarction and target lesion revascularization)  and angiographic
stent patency was also evaluated by MS-CT coronarography.
Tryton device
The Tryton Side Branch Stent (Tryton Medical, USA), which was
used by us, is a chromium–cobalt stent consisting of three parts:
the distal segment is a common stent for implantation in thel LAD and Dx1. (A) Left anterior oblique 458, caudal 458 view;
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the proximal segment to ﬁt in the main branch. The stent allows
simple performance of the ‘‘reverse culotte technique’’ [4].
Interventional procedure
Coronary intervention was performed at the Siemens Axiom
device (Forcheim, Germany) by the standard method from the
right or left radial approach using the 6F guiding catheters.
After wiring of both the main vessel and the side branch
and predilation, the Tryton Side Branch Stent is advancedFig. 2 – Process of dedicated Tryton stent implantation, right ante
(B) Tryton stent implantation; (C) final kissing postdilation.over the wire into the side branch, and using the two
middle markers on the delivery system, the stent is
positioned till these markers straddle the side branch
origin. Deployment of the stent is followed by retraction of
the guidewire from the side branch and repositioning it
through the fronds of the transition zone into the distal
main vessel. A standard stent is then advanced and
positioned in the main vessel jailing the stented side
branch. Once the main vessel stent is deployed re-crossing
into the side branch allows ﬁnal kissing balloon inﬂation [4]
(Figs. 1–6).rior oblique 258, cranial 408 view: (A) Tryton stent placement;
Fig. 3 – Case 1, final results. (A) Right anterior oblique 258, cranial 408 view; (B) left anterior oblique 208, cranial 408 view.
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The patients received standard dual antiaggregation therapy
(clopidogrel 75 mg and ASA 100 mg/day), beta-blockers and
statins, with 6-month follow-up. Clinical examination was
performed, any MACE were recorded and MS-CT coronaro-
graphy was performed.Fig. 4 – Case 2, tight bifurcation stenosis Medina 1,1,1 at proxima
(B) left anterior oblique 458, caudal 458 view.Multi-slice CT coronarography
All patients were examined without the need of previous
premedication with beta-blockers in the Siemens Somatom
Deﬁnition AS+ device (Forcheim, Germany). It is a single source
CT scanner in a 128-slice conﬁguration. The scanning mode
cardiacCT (CT Syngo 2011) with retrospective ECG gating wasl LAD and Dx1. (A) Left anterior oblique 208, cranial 408 view;
Fig. 5 – Tryton stent implantation, left anterior oblique 458,
caudal 458 view.
Table 1 – Demographic characteristics.
Age 62.85  9.9
Male 35 (83.33%)
Female 7 (16.67%)
Diabetes mellitus 11 (26.19%)
Renal failure 1 (2.38%)
Ejection fraction (%) 53.55  9.27
CABG 1 (2.38%)
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were reconstructed in various phases of cardiac cycle to
minimize the movement artifacts in the stents. Evaluation in
the soft and hard kernel (B30f, B46f) was used for each stent to
reduce the effects of the artifacts. The ﬁnal scans including
evaluation of the in-stent restenosis grade were performed
using the reconstruction software Aquarious iNTUITION (Tera
Recon, Foster City, CA, USA). The MIP reconstructions, curvedFig. 6 – Case 2, final results. (A) Right anterior oblique 258, cranMIP and automatic software Vessel analysis were used for
evaluation of the lumen (Fig. 7).
Statistical analysis
Continuous variables are presented as means  standard
deviations; categorical variables are presented as counts and
percentages. For the most important endpoints of the study, 95%
conﬁdence intervals of the single point estimates were calculat-
ed using the dedicated software Statistica 12 (StatSoft, OK, USA).
Results
A total of 42 patients with bifurcation lesions were included in
our registry. The group's demographic data are presented in
Table 1.
Twenty-two patients (52.38%) were treated for acute
coronary syndromes; one patient with critical stenosis of
the distal left main stem was in cardiogenic shock. Thirty-nine
(92.85%) lesions were ‘‘true bifurcations’’ (Medina 1,1,1; 1,0,1
and 0,1,1). The characteristics and locations of the lesions are
presented in Table 2 and Graph 1.
The mean diameters (SD) of the proximal and distal
segments of the main branch and the side branch wereial 408 view; (B) left anterior oblique 458, caudal 458 view.
Fig. 7 – 6-Month follow-up; MS-CT volume-rendered 3-D
image; patent Tryton stent.
Less ion localisa tion
LAD x RD  
34 (80,9%)
LCX x OM 2 (4,8%)
RCA x PDA x PDL 
4 (9,5% )
LM di st  1 (2,4%)
SVG 1 (2,4%)
LM dist
LAD x Dx
LCX x OM
RCA x PDA x PDL
SVG
Graph 1
Tryton ste nts
5 (12%)
5 (12% )
1  (2%)
22 (53%)
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bifurcation lesions with signiﬁcant side branches were involved.
The mean lesion length in the main branch was 24.5  7.06 mm.
The sizes of the Tryton stents are shown in Graph 2.
A drug eluting stent as a second stent was implanted in the
main branch in 54.8% of the cases. In one case, implantation of
a bare metal stent was preceded by predilation with a drug
eluting balloon catheter due to the need for early non-cardiac
surgery. Due to the length of the lesion or to existing edge
dissection, another stent was implanted into the side branch
in 6 (14.3%) cases and into the main branch in 4 (9.5%) cases.
Tryton stent implantation was successful in 100% of the
lesions. The stent was distorted during the procedure in one
case; the next Tryton stent was smoothly introduced following
repeated predilation. In one case, presumably due to aggres-
sive ﬁnal kissing postdilation, paravasal leak of the contrastTable 2 – Lesion characteristics.
Medina classiﬁcation
1,1,1 33 (78.57%)
0,1,1 6 (14.28%)
1,1,0 2 (4.76%)
0,0,1 1 (2.38%)agent was apparent, however, without development of the
hemopericardium or need for pericardiocentesis. Final kissing
postdilation was performed in 100% of the lesions.
The 6-month clinical follow-up was performed in all
patients. The 6-month MACE rate (cardiac death, myocardial
infarction and target lesion revascularization) was 9.52% (95%
CI: 2.66–22.62%). One patient (2.38%; 95% CI: 0.06–12.57%) died
of a cardiogenic shock caused by early stent thrombosis. Three
patients (7.14%; 95% CI: 1.50–19.48%) required repeated
revascularization (TVR) due to in-stent restenosis, all of them
arise in bare metal stents. Furthermore, one non-cardial death
due to generalized lung cancer was recorded.
Thirty-six (85.71%) patients were without limiting effort
angina pectoris (CCS class 0–1).
A 6-month MS-CT coronarography was performed in 39
(92.85%) patients. The implanted bifurcation Tryton stents
were satisfactorily visualized in 38 of them (97.43%); one small
side branch (2.5 mm) of the Tryton stent was not evaluable due
to blooming artifacts. The above-mentioned in-stent resteno-
sis was detected in one patient, requiring subsequent rePCI.
The remaining 37 implanted Tryton stents (88.1%) demon-
strated satisfactory 6-month angiographic patency by MS-CT.9 (21%)
3,5/2,5x19
3,5/3x18
3/2,5x19
4/3,5x18
4/3,5x15
Graph 2
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Many strategies have been evaluated in the treatment of
coronary bifurcation lesions.
In the NORDIC study a total of 413 patients with a
bifurcation lesion were randomized to compare a strategy of
stenting both the main vessel and the side branch with a
strategy of stenting the main vessel only (and optional
stenting of the side branch) using sirolimus-eluting stents.
In the main vessel + side branch group several different
techniques were used (culotte, crush, T-stenting, etc.).
In this trial a very low rate of major adverse cardiovascular
events was seen in both groups at 6-month follow-up with no
signiﬁcant difference (2.9% vs. 3.4%, NS) [5].
In the BBC ONE study, 500 patients with bifurcation lesions
were randomized to either a provisional T-stent strategy or full
lesion coverage with either culotte or crush technique. A
signiﬁcant difference was observed between the MACE rates in
the complex group vs. that in the simple group (15% vs. 8%,
P = 0.009). This was largely driven by a higher incidence of
periprocedural myocardial infarction in the complex group [6].
In the CACTUS study 350 patients with coronary bifurca-
tions were randomized to crush or provisional T-stenting
using sirolimus stents. Kissing balloon inﬂations were
mandated in both groups, and were achieved in above 90%.
The primary clinical endpoint (6-month MACE) was similar in
the two groups (16% vs. 15%, P = NS), and there was no
difference in the rate of angiographic restenosis in either the
main or side branch [7].
According to the consensus of the European Bifurcation
Club, nowadays provisional T-stenting is considered the
golden standard of treatment for most bifurcation lesions.
Stent implantation into a side branch (SB) is only required if a
signiﬁcant impairment of its ostia persists following the ﬁnal
kissing postdilation (dissection, residual stenosis greater than
75%, TIMI ﬂow class below 3 in SB ≥ 2.5 mm or FFR below 0.75).
In contrast, bifurcation lesions with involvement of a large
SB, which exceeds 5 mm from the carina, usually primarily
require the implantation of two stents. In this case the culotte
technique brings some advantages over the crush technique
(signiﬁcantly lower periprocedural AMI and ISR) [8,9].
In a real world the use of the Tryton Side Branch Stent was
studied in two registries.
In the E-Tryton registry, 302 patients with coronary
bifurcation lesions underwent treatment with the Tryton
stent, in conjunction with a main branch stent (drug-eluting in
88% cases). Procedural success occurred in 94% patients. The
primary endpoint, 6-month MACE (cardiac death, myocardial
infarction and target lesion revascularization) rate was 6.4%,
including 4.7% myocardial infarctions (3.7% periprocedural)
and 3.4% target lesion revascularizations and 1 stent throm-
bosis (0.3%) [10].
In the Rotterdam–Poznan registry there were 96 patients
with 100 lesions included. Procedural success rate reached
94%. At a 6-month follow-up, TVR rate was 4%, MI 3%, and
cardiac death 1%. The percentage MACE-free survival at 6
months was 94%.
Both these registries show that the treatment of bifurcation
lesions with a dedicated Tryton stent is safe and feasible, withgood technical and procedural success and low major adverse
cardiac events at 6-month clinical follow-up [11].
Thirty-nine (92.85%) lesions in our study group were ‘‘true
bifurcations’’. The true bifurcation lesions are reported to
lesions involving the main branch and ostium of the side
branch (Medina 1,1,1; 1,0,1 and 0,1,1).
In comparison with the above-mentioned registries, our
patients constituted a higher-risk group, with a larger
proportion of acute coronary syndromes (55  3% and 24.5%).
One patient died due to early stent thrombosis after
implantation of a bifurcation and drug eluting stent into the
LM for acute myocardial infarction complicated by a cardio-
genic shock, in possible relation with temporarily ineffective
antiaggregation due to a bleeding stress ulcer.
Repeated target vessel revascularization (TVR) was neces-
sary in three patients (7.14%), in all cases due to in-stent
restenosis (ISR) in the second bare metal stent. The in-stent
restenosis was clinically manifested as a relapse of effort angina
pectoris and was treated by drug eluting balloon catheters, with
persisting satisfactory results (no additional 6-month MACE).
The relatively large fraction of bare metal stents implanted
in the main branch in our patient group was primarily due to
the impossibility of long-term dual antiaggregation in such
patients (urgent non-cardial surgery, risk of bleeding from the
gastrointestinal tract, necessity of permanent anticoagulation
due to artiﬁcial heart valve or for an atrial ﬁbrillation with a
recent cardioembolic stroke).
In one patient the Tryton stent was successfully implanted
into the bifurcation lesion on a Y-shaped vein graft, which
gave rise to an interesting case study [12].
Duration of dual antiplatelet therapy after the Tryton stent
implantation is mostly inﬂuenced by the type of the secondstent
implanted into the main vessel, with respect to the preferred use
of DES dual antiplatelet therapy administered for 6–12 months.
We used multi-slice CT coronary angiography to demon-
strate the long-term patency of the implanted stents. Usage of
CT coronarography in the demonstration of in-stent rest-
enoses was assessed by Sun in his meta-analysis. The
sensitivity and speciﬁcity of the 64-slice CT angiography in
the detection of in-stent restenoses were 90% and 91%,
respectively. The mean value of assessable stents was 89–
91%. Signiﬁcantly higher diagnostic success was achieved
during the evaluation of stents with the diameter greater than
3 mm (in comparison with stents under 2.75 or 2.5 mm) [13].
Our own data from another study also show that MS-CT
coronarography is able to detect coronary in-stent restenosis
with sufﬁcient reliability (with sensitivity 80% and speciﬁcity
97.1%; 94.1% positive and 89.2% negative predictive values) [14].
A major obstacle of the stent lumen visualization is
artifacts caused by the dense stent material. Although imaging
of two overlapping stents by MS-CT coronarography is
difﬁcult, we achieved satisfactory visualization in 97.43% of
bifurcation stents.
Conclusion
The use of a dedicated bifurcation Tryton Side Branch Stent for
PCI of the bifurcation lesions is technically feasible with
satisfactory long-term results. This type of stent is beneﬁcial
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 4 7 8 – e 4 8 5 e485especially in the treatment of bifurcation lesions with involve-
ment of a large SB, which exceeds 5 mm from the carina that
usually primarily require the implantation of two stents [8,9].
MS-CT coronarography is a reliable method of stent imaging
event if two overlapping stents are to be visualized.
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